Global Transgenic Animals Market Size Likely to Grow at a CAGR of 10.1% By 2035

It is projected that the market size of the global transgenic animals market will be USD 3.42 billion in 2025, and that the market size will increase to USD 3.76 billion in 2026 and to approximately USD 7.89 billion in 2035, at an annual CAGR of 10.1% between 2025 and 2035.

Transgenic Animals Market Revenue and Trends

Transgenic animals (mostly mice, rats, zebrafish, pigs, goats, and cattle) engineered to express foreign genes to be used in biomedical research, drug discovery, disease modeling, xenotransplantation, and biopharmaceutical production are also traded on the global market. With rising demand for specific disease models, emerging investment in personalised medicine and gene therapy, expansion in the need for large animal models in regenerative medicine and new CRISPR/Cas9, TALENs, and next-generation genome editing technology in biomedical and pharmaceutical ecosystems across the globe, the transgenic animals market is expanding at a rapid rate.

What are the Factors That Have a Significant Contribution to the Growth of the transgenic animals market?

The increased demand for transgenic animal products has been stimulated by the rise of complicated human disease research (cancer, Alzheimer's, cardiovascular, and rare genetic diseases) due to the shortcomings of traditional models and the need to have more precise translational research. With increased focus on targeted therapies in pharmaceutical pipelines and the adoption of more sophisticated models in preclinical research by regulatory agencies, an increasing number of biotech and pharma companies will require custom transgenic lines to obtain reliable data on efficacy and safety.

The technology has brought new methods such as multiplex CRISPR editing, conditional/tissue-specific knock-ins, humanized animal models, and rapid generation platforms which have saved time-to-model and enhanced accuracy. Other reasons are the additional funding for research into rare diseases, broader use as a xenotransplantation (e.g. pig-to-human), expanding biopharming uses, and biomedical research grants and ethical framework development in the developed and emerging areas funded by governments.

Segment Insight

By Product Type

Transgenic mice, by products, were as of 2025 the largest share of the transgenic animals market by far, with strong demand in academic research, oncology, neurology and drug discovery markets having largely relied on them due to their well-characterized genetics, short generation time and extensive repository of established lines, and where further innovations in CRISPR-engineered and humanized and conditional knockout models are cited by large numbers of researchers as having made them their better choice of tool in accelerating discovery and improving translational relevance.

By Distribution Channel

The greatest market share is in direct sales with specialized breeders and contract research organizations (CROs) as the main source of custom model production, proprietary lines licensing, technical support and colony management services. These channels have become the choice of source of transgenic animals since they offer professional skills in the strain designing, genotyping, health monitoring, and regulatory compliance.

Regional Insights

North America controls the world transgenic animals market due to the developed biomedical research facilities, high R&D spending by pharma/biotech, and more use of sophisticated genome editing technology. North America can also enjoy the advantages of strong funding (NIH, private foundations) and extensive access to specialized facilities as well as the early implementation of CRISPR-based and humanized models. The availability of key players in the industries as well as the existence of innovation and translational research contribute to the further leading role of North America.

More so, the Asia Pacific region is registering the most growth rate in the transgenic animals market due to its fast developing biotech industry, growing investment in life sciences, an increase in CROs, and growing interest in precision medicine. The adoption of transgenic models in China, India, Japan, and South Korea has been observed to increase noticeably due to the affordability, improvement in local R&D strengths, and the existence of biomedical innovation programs that are supported by the government. The speeding up of pharma R&D outsourcing, collaborations with academic institutions and rare disease research in this region will help in the fast market growth in the region of Asia Pacific.

Report Scope

Recent Developments

• In December 2025: eGenesis announced successful long-term survival of genetically engineered porcine kidneys in non-human primate recipients using advanced multi-gene CRISPR editing, marking a major milestone toward clinical xenotransplantation and expanding the application scope of transgenic large animals.

List of the prominent players in the Transgenic Animals Market:

• The Jackson Laboratory

• Charles River Laboratories

• Taconic Biosciences

• genOway S.A.

• Horizon Discovery Group

• Cyagen Biosciences

• PolyGene Transgenics

• Trans Genic Inc.

• Ingenious Targeting Laboratory

• Ozgene Pty Ltd

• Applied StemCell

• Others

The Transgenic Animals Market is segmented as follows:

By Type

• Mice

• Rats

• Rabbits

• Pigs

• Cattle

• Others

By Application

• Research & Development

• Biopharmaceutical Production

• Disease Modeling

• Xenotransplantation

• Others

By Technology

• Microinjection

• Gene Editing (CRISPR/Cas9)

• Retroviral Vector

• Others

By End User

• Pharmaceutical & Biotechnology Companies

• Academic & Research Institutes

• Contract Research Organizations

• Others

Regional Coverage:

North America

• U.S.

• Canada

• Mexico

• Rest of North America 

Europe

• Germany

• France

• U.K.

• Russia

• Italy

• Spain

• Netherlands

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• New Zealand

• Australia

• South Korea

• Taiwan

• Rest of Asia Pacific 

The Middle East & Africa

• Saudi Arabia

• UAE

• Egypt

• Kuwait

• South Africa

• Rest of the Middle East & Africa

Latin America

• Brazil

• Argentina

• Rest of Latin America